Moreover, tyrosine kinase receptor (TKR)-targeted antibodies and tyrosine kinase inhibitor (TKI) related micro molecules have aroused another ray of hope in treating different cancers by blocking the TKR and subsequent molecular signaling [108]. The gene discussed is TKTL1; the disease is cancer.